Lung cancer patient channels diagnosis into lifetime activism
By any measure, lung cancer patients have it rough.
Mar 21, 2019
0
0
By any measure, lung cancer patients have it rough.
Mar 21, 2019
0
0
Women diagnosed with non-small cell lung cancers (NSCLC) live longer than their male counterparts, according to results of a SWOG study presented today by Kathy Albain, MD, the Huizenga Family Endowed Chair in Oncology Research ...
Sep 24, 2018
0
4
New research shows that treating stage II and III non-small cell lung cancer (NSCLC) N+ resected patients with customized chemotherapy (CT) treatment based on their specific BRCA1 expression levels, as opposed to providing ...
Oct 17, 2017
0
0
A new analysis finds that, despite advances in care, men and women with a diagnosis of heart failure continue to have worse survival rates than patients with certain common cancers.
May 4, 2017
0
0
Current guidelines from the National Comprehensive Cancer Network (NCCN) and American College of Chest Physicians (ACCP) recommend that operable patients with clinical Stage IIIA non-small cell lung cancer (NSCLC) should ...
May 16, 2016
0
0
Patients with recurrent lung cancer have better post-surgery survival rates if their management includes a follow-up programme based on computer tomography (CT) of the chest, according to new findings.
Sep 27, 2015
0
18
Scientists from the Instituto de Investigación Biomédica (IBI) [Institute of Biomedical Research], in Galicia (Spain), have made progress in the identification of new biomarkers for improving prevention of colorectal cancer.
Jul 1, 2015
0
6
Low pre-surgery uptake of a labeled glucose analogue, a marker of metabolic activity, in the primary tumor of patients with stage I non-small cell lung cancer (NSCLC) is associated with increased overall survival and a longer ...
Mar 30, 2015
0
3
Remarkable improvements in cancer survival mean that half of all people diagnosed with cancer today (2010-11) in England and Wales are expected to survive from their cancer for at least 10 years, compared to just a quarter ...
Dec 3, 2014
0
0
Computer-Aided Nodule Assessment and Risk Yield, is a novel software tool developed at Mayo Clinic that can automatically quantitate adenocarcinoma pulmonary nodule characteristics from non-invasive high resolution computed ...
Oct 23, 2014
0
0